TIMP2 and uterine cervix carcinoma in situ: Regarding cervical cancer progression, Fernandes et al. (2008) found a progressive enhancement of MMP-2 expression in stromal cells from CIN III to cervical invasive carcinoma [45], possibly due to an imbalance with its main inhibitor, TIMP-2.